Compounds > 3'-fluorothymidine-5'-triphosphate
Page last updated: 2024-09-04

3'-fluorothymidine-5'-triphosphate and sofosbuvir

3'-fluorothymidine-5'-triphosphate has been researched along with sofosbuvir in 1 studies

Compound Research Comparison

Studies
(3'-fluorothymidine-5'-triphosphate)		Trials
(3'-fluorothymidine-5'-triphosphate)		Recent Studies (post-2010)
(3'-fluorothymidine-5'-triphosphate)		Studies
(sofosbuvir)		Trials
(sofosbuvir)		Recent Studies (post-2010) (sofosbuvir)
7012,1643182,064

Protein Interaction Comparison

ProteinTaxonomy3'-fluorothymidine-5'-triphosphate (IC50)sofosbuvir (IC50)
Cytochrome P450 3A4Homo sapiens (human)8.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chien, M; Jockusch, S; Ju, J; Kalachikov, S; Kirchdoerfer, RN; Kumar, S; Li, X; Morozova, I; Russo, JJ; Tao, C1

Other Studies

1 other study(ies) available for 3'-fluorothymidine-5'-triphosphate and sofosbuvir

ArticleYear
Nucleotide analogues as inhibitors of SARS-CoV Polymerase.
    Pharmacology research & perspectives, 2020, Volume: 8, Issue:6

    Topics: Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Dideoxynucleotides; Drug Combinations; Heterocyclic Compounds, 4 or More Rings; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sofosbuvir; Thymine Nucleotides; Zidovudine

2020